[1]Kuo MT, Chen HH, Song IS, et al.The role of copper trans-porters in cisplatin resistance[J].Cancer Metastasis Rev, 2007, 26 (1) :71-83.
|
[2]Goli Samimi, Nissi MV, Sharon W, et al.Increase in expres-sion of the copper transporter ATP7A during platinum drug-based treatment is associated with poor survial in ovariancancer patients[J].Clin Cancer Res, 2003, 9 (16pt1) :5853-5859.
|
[3]Masahide O, Kenji O, Soichi K, et al.Copper-transportingP-type adenosine triphosphatase (ATP7B) is expressed inhuman gastric carcinoma[J].Cancer Letters, 2003, 189 (1) :33-38.
|
[4]王树滨, 刘雅洁, 陈亦欣, 等.P型铜转运ATP酶 (ATP7B) 在乳腺癌组织中的表达及与预后的关系[J].实用肿瘤学杂志, 2006, 20 (3) :161-164.
|
[5]杨秉辉, 夏景林.“原发生肝癌的临床诊断与分期标准”及说明[J].肿瘤, 2002, 22 (1) :5.
|
[6]Mufti AR, Burstein E, Csomos RA, et al.XIAP is a copperbinding protein deregulated in Wilson’s disease and othercopper toxicosis disorders[J].Molecular Cell, 2006, 21 (6) :775-785.
|
[7]汤钊猷.从生物学角度看肝癌[J].医学研究杂志, 2008, 27 (1) :1-3.
|